CBLL Stock Overview
Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
CeriBell, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$15.00 |
| 52 Week High | US$32.75 |
| 52 Week Low | US$10.01 |
| Beta | 0 |
| 1 Month Change | -28.67% |
| 3 Month Change | -21.42% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -40.00% |
Recent News & Updates
Shareholder Returns
| CBLL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -17.5% | 1.9% | 5.8% |
| 1Y | n/a | 1.7% | 4.8% |
Return vs Industry: Insufficient data to determine how CBLL performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how CBLL performed against the US Market.
Price Volatility
| CBLL volatility | |
|---|---|
| CBLL Average Weekly Movement | 17.7% |
| Medical Equipment Industry Average Movement | 8.7% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 4.1% |
Stable Share Price: CBLL's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CBLL's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 281 | Jane Chao | www.ceribell.com |
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband.
CeriBell, Inc. Fundamentals Summary
| CBLL fundamental statistics | |
|---|---|
| Market cap | US$538.03m |
| Earnings (TTM) | -US$40.45m |
| Revenue (TTM) | US$65.44m |
8.2x
P/S Ratio-13.3x
P/E RatioIs CBLL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBLL income statement (TTM) | |
|---|---|
| Revenue | US$65.44m |
| Cost of Revenue | US$8.69m |
| Gross Profit | US$56.75m |
| Other Expenses | US$97.21m |
| Earnings | -US$40.45m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.13 |
| Gross Margin | 86.72% |
| Net Profit Margin | -61.82% |
| Debt/Equity Ratio | 10.2% |
How did CBLL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 08:22 |
| End of Day Share Price | 2025/04/11 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CeriBell, Inc. is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | BofA Global Research |
| William Plovanic | Canaccord Genuity |
| Robert Marcus | J.P. Morgan |